Frazier Life Sciences Management, L.P.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1892134 PALO ALTO, CA

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$18,470,152

+$18,166,119 QoQ

Shares Held

4,925,374

+1763.0% QoQ

Ownership

3.53%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Frazier Life Sciences Management, L.P. holds $3,802,745,091 across 34 Biotechnology names. ACRS ranks #26 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	7,679,684	$709,449,207
2	NAMS	NewAmsterdam Pharma Co N.V.	16,943,774	$542,370,205
3	ERAS	Erasca, Inc.	24,675,188	$399,244,541
4	BBIO	BridgeBio Pharma, Inc.	3,448,139	$256,058,802
5	ARQT	Arcutis Biotherapeutics, Inc.	9,874,511	$232,643,479
6	MBX	MBX Biosciences, Inc.	6,652,013	$198,562,588
7	PHAT	Phathom Pharmaceuticals, Inc.	12,466,489	$138,502,692
8	MAZE	Maze Therapeutics, Inc.	4,567,274	$136,333,128

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,470,152	4,925,374	+1763.0%	Shares	Sole	2026-05-15
2024-09-30	$304,033	264,377	0.0%	Shares	Sole	2024-11-15
2024-06-30	$290,814	264,377	0.0%	Shares	Sole	2024-08-15
2024-03-31	$327,827	264,377	0.0%	Shares	Sole	2024-05-15
2023-12-31	$277,595	264,377	0.0%	Shares	Sole	2024-02-14
2023-09-30	$1,810,982	264,377	0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,741,589	264,377	0.0%	Shares	Sole	2023-08-14
2023-03-31	$2,138,809	264,377	-8.9%	Shares	Sole	2023-05-15
2022-12-31	$4,570,476	290,189	-28.9%	Shares	Sole	2023-02-07
2022-09-30	$6,427,098	408,329	0.0%	Shares	Sole	2022-11-14
2022-06-30	$5,700,272	408,329	0.0%	Shares	Sole	2022-08-10
2022-03-31	$7,039,591	408,329	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.